5-hydroxymethylcytosine loss in conjunctival melanoma

Stahl, Alexandre; Riggi, Nicolo; Nardou, Katya; Nicolas, Michael; Kaya, Gurkan; Moulin, Alexandre

doi:10.3390/dermatopathology8020023

Scientific article

English

5-hydroxymethylcytosine loss in conjunctival melanoma

ContributorsStahl, Alexandre; Riggi, Nicolo; Nardou, Katya; Nicolas, Michael; Kaya, Gurkan; Moulin, Alexandre

Published inDermatopathology, vol. 8, no. 2, p. 176-184

Publication date2021

Abstract

Conjunctival and cutaneous melanoma partially share similar clinical and molecular backgrounds. As 5-hydroxymethylcytosine (5-hmC) loss has been demonstrated in cutaneous melanoma, we decided to assess if similar changes were occurring in conjunctival melanoma.

Affiliation entities

Research groups

Rôle du CD44 (809)

Citation (ISO format)

STAHL, Alexandre et al. 5-hydroxymethylcytosine loss in conjunctival melanoma. In: Dermatopathology, 2021, vol. 8, n° 2, p. 176–184. doi: 10.3390/dermatopathology8020023

Article (Published version)

CC BY

Identifiers

PID : unige:154113
DOI : 10.3390/dermatopathology8020023
PMID : 34198758

Journal ISSN2296-3529

206views

133downloads

Creation27/07/2021 16:11:00

First validation27/07/2021 16:11:00

Update time16/03/2023 01:07:27

Status update16/03/2023 01:07:26

Last indexation31/10/2024 22:51:32

Archive ouverte UNIGE

5-hydroxymethylcytosine loss in conjunctival melanoma

Conjunctival and cutaneous melanoma partially share similar clinical and molecular backgrounds. As 5-hydroxymethylcytosine (5-hmC) loss has been demonstrated in cutaneous melanoma, we decided to assess if similar changes were occurring in conjunctival melanoma.

Technical informations